Stefanos Zenios

Charles A. Holloway Professor of Operations, Information and Technology

Professor of Health Care Management

Professor of Bioengineering (by courtesy), Department of Bioengineering, Schools of Medicine & Engineering

Director, Center for Entrepreneurial Studies

Professor Zenios studies how health care delivery systems use technology to prolong life and improve its quality for patients with complex and expensive medical needs. He is especially interested in the impact the decisions of providers and payers have on the innovators. Some of the issues he examines include: medical technology adoption through shared decision making between physicians and patients; financial incentives for the adoption and initiation of complex treatments; evidence-based decision making and its effect on equitable utilization of medical technology; and early-stage business models in medical technology.

Bio

Stefanos Zenios is the Charles A. Holloway Professor of Operations, Information and Technology at the Graduate School of Business, Stanford University. His research is concerned with how health care delivery systems use technology to prolong life and improve its quality for patients with complex and expensive medical needs. He is especially interested in the impact the decisions of providers and payers have on the innovators. Some of the issues he examines include: medical technology adoption through shared decision making between physicians and patients; financial incentives for the adoption and initiation of complex treatments; differences in the utilization of medical technology and outcomes between for-profit and nonprofit health care providers; evidence-based decision making and its effect on equitable utilization of medical technology; the value of life implied by existing medical practice and its implications; and early-stage business models in medical technology. Professor Zenios has explored these questions in the context of end-stage organ failure and particularly kidney failure. His research was supported by grants from the NIH, by the prestigious CAREER award from NSF, and by Stanford Hospital and Clinic. He is now expanding his analysis to other conditions such as cardiovascular diseases.

In addition, he teaches two MBA courses: In Health Care Management and Innovation the students examine the strategic forces that shape market-based health care systems, the quality of care delivered in such systems, and the incentives for innovation. In Biodesign Innovation, co-taught with Dr. Paul Yock and Dr. Josh Mackower from the Biodesign Program at Stanford University, interdisciplinary teams of students from the Business School, Medical School, and School of Engineering develop prototypes for medical devices to address important unmet medical needs and business plans to commercialize these products.

He has also consulted extensively to companies in the life science sector, helping them redesign their product development and delivery processes in response to shifting market conditions. He is the co-founder of Culmini Inc., a company that develops interactive guides to medical treatments for patients and families. These guides can be found at www.konnectology.com.

A native of Cyprus, Professor Zenios received a BA and MA in Mathematics from Cambridge University, England, and a PhD in Operations Research from MIT.

Academic Degrees

PhD, M.I.T., 1996; Dissertation Fellowship, Health Care Financing Administration, 1996; MA, Univ. of Cambridge, 1996; BA, Univ. of Cambridge, 1992.

Professional Experience

At Stanford since 1996.

Selected Publications

Working Papers

  • 1522R: Managing the Delivery of Dialysis Therapy: A Multiclass Fluid Model Analysis
  • 1552: Evidence-Based Organ Allocation
  • 1684: Primum Non Nocere: Avoiding Harm to Vulnerable Wait List Candidates in an Indirect Kidney Exchange

Selected Cases

  • OIT80: Exubera and NICE
  • OIT81A: Negotiating Partnerships in the Healthcare Industry (A): The Pharmac and Respire Deal
  • OIT93: AthenaHealth: Innovating at the Point of Delivery
  • OIT97: Biodesign: Innovating for the Underserved
  • OIT102: Innovating for the Safety Net: Sources of Funding
  • OIT101A: Stanford Hospital and Clinics (A): Building the Business Case for an Electronic Medical Records System
  • OIT100: Innovating for the Safety Net: Practical Considerations
  • OIT41: Process Improvement in Stanford Hospital's Operating Room
  • OIT44: Abbott Laboratories And HUMIRA: Launching A Blockbuster Drug
  • OIT43: Note on Employer-Provided Health Insurance
  • OIT46: United Resource Networks: Facilitating Win-Win-Win Solutions in Organ Transplantation
  • OIT44 Condensed: Abbott Laboratories and HUMIRA: Launching A Blockbuster Drug
  • OIT42: BENU: Bringing Consumer Competition to Health Insurance
  • OIT50: Drug Eluting Stents: A Paradigm Shift in the Medical Device Industry
  • OIT49: Genomic Health: Launching a Paradigm Shift ... and an Innovative New Test
  • OIT81B: Negotiating Partnerships in the Healthcare Industry (B): The Pharmac and Respire Deal
  • E214: EndoNav
  • OIT51: Challenges in Renal Care
  • OIT101B: Stanford Hospital and Clinics (B): New Incentives for an Electronic Medical Records System
  • OIT98: Emphasys Medical: Navigating Complex Clinical and Regulatory Challenges on the Path to Market
  • OIT103: Electronic Medical Records System Implementation at Stanford Hospital and Clinics

Awards and Honors

  • CAREER Award, 2000, National Science Foundation
  • George E. Nicholson Award for Best Student Paper, 1997, Institute for Operations Research and Management Sciences
  • Dissertationa Fellowship, 1996, Health Care Financing Administration

Courses Taught

Centers/Programs

In The Media